The Special Activity of Stone–Wales Defect Graphene for the Oxygen Reduction Reaction: A Comparison Study between the Charge-Neutral Model and the Constant Potential Model Calculated by Density Functional Theory
The Journal of Physical Chemistry C · 29.02.2024 · 128 (8) · 3250-3259
DOI: 10.1021/acs.jpcc.3c08035 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry C, online erschienen am 19.02.2024. Verfasst von Pengfei Yuan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Yuan, P., Li, C., Zhang, J., Wang, F., & Chen, X. (2024). The Special Activity of Stone–Wales Defect Graphene for the Oxygen Reduction Reaction: A Comparison Study between the Charge-Neutral Model and the Constant Potential Model Calculated by Density Functional Theory. The Journal of Physical Chemistry C, 128(8), 3250-3259. https://doi.org/10.1021/acs.jpcc.3c08035
Vancouver
Yuan P, Li C, Zhang J, Wang F, Chen X. The Special Activity of Stone–Wales Defect Graphene for the Oxygen Reduction Reaction: A Comparison Study between the Charge-Neutral Model and the Constant Potential Model Calculated by Density Functional Theory. The Journal of Physical Chemistry C. 2024;128(8):3250-3259. doi:10.1021/acs.jpcc.3c08035
BibTeX
@article{Yuan2024,
author = {Yuan, Pengfei and Li, Chong and Zhang, Jianan and Wang, Fei and Chen, Xuebo},
title = {The Special Activity of Stone–Wales Defect Graphene for the Oxygen Reduction Reaction: A Comparison Study between the Charge-Neutral Model and the Constant Potential Model Calculated by Density Functional Theory},
journal = {The Journal of Physical Chemistry C},
year = {2024},
volume = {128},
number = {8},
pages = {3250--3259},
doi = {10.1021/acs.jpcc.3c08035}
}
EUVIMED